Avalo Therapeutics, Inc.·4

Jun 18, 4:08 PM ET

Jain Rita 4

4 · Avalo Therapeutics, Inc. · Filed Jun 18, 2025

Insider Transaction Report

Form 4
Period: 2025-06-17
Jain Rita
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-17+40,20040,200 total
    Exercise: $4.47Exp: 2035-06-17Common Stock (40,200 underlying)
Footnotes (1)
  • [F1]The stock option vests in three substantially equal installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT